Oncolytic virotherapy in Treatment of Colorectal Cancer
Virotherapy has proved to be a more effective treatment for colorectal cancer, considering that it successfully prevents the reoccurrence of the disease when used as therapy of choice. Oncolytic virotherapy…
Oncolytic Virotherapy and Cancer Treatment
Oncolytic virotherapy has since proved to be a major perspective in the development of new treatments of cancer. Oncolytic viruses are attributed with oncotropism and oncolytism; which are two important…
Effectiveness of Oncolytic Virotherapy in Cancer Treatment
Oncolytic viruses are currently being used as new treatment interventions for cancer. Oncolytic viruses are selective in the manner they target and destroy cancer cells without affecting healthy cells. The…
Acral Lentiginous Melanoma
Uncontrolled growth of melanocytes, pigment cells found in the epidermal layer of skin, is called a MELANOMA or skin cancer in simple terms. This growth may be Non-cancerous resulting in…
Integrative targeted therapy for renal cancer
Facts about kidney (also called renal) cancer: Cancer of the kidneys is the sixth most common cancer for men and the eighth most common cancer for women. Approximately 85% of…
A progressive stage IIIB melanoma treated with oncolytic ECHO-7 virus: A case report
Melanoma is an aggressive skin cancer form with a grave prognosis. Current results suggest that oncolytic virus treatment of melanoma has a high therapeutic potential. ECHO-7 (Rigvir) is the first…
Management of a primary malignant melanoma of uterine cervix stage IVA patient with radical surgery and adjuvant oncolytic virus Rigvir® therapy: A case report
A 25‐year‐old nulliparous woman was diagnosed with a primary malignant melanoma of the uterine cervix stage IVA. She has undergone surgery three times. The oncolytic virus Rigvir® was prescribed between the…
Rigvir holding concludes a deal with Chinese biotech company Sinorda Biomedicine on development and commercialisation of Oncolytic virotherapy cancer medicine in Chinese market
Rigvir holding concludes a deal with Chinese biotech company Sinorda Biomedicine on development and commercialisation of ECHO-7 oncolytic virotherapy cancer medicine in Chinese market and agrees on sales of minority…
